Financials in USD. Standardized financial statements.
A compact view of how Blonder Tongue Laboratories, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $11.16M | $13.21M | $18.11M | $15.75M | $16.38M | $19.84M | $21.71M | $23.28M | $22.51M | $20.94M |
| Revenue Growth? | -15.5% | -27.1% | +15.0% | -3.8% | -17.5% | -8.6% | -6.8% | +3.5% | +7.5% | 0.0% |
| Cost of Revenue? | $7.46M | $9.23M | $12.65M | $9.90M | $13.36M | $16.41M | $13.29M | $14.35M | $14.15M | $16.79M |
| Gross Profit? | $3.71M | $3.98M | $5.46M | $5.86M | $3.02M | $3.43M | $8.42M | $8.94M | $8.36M | $4.16M |
| Gross Margin? | +33.2% | +30.1% | +30.2% | +37.2% | +18.4% | +17.3% | +38.8% | +38.4% | +37.1% | +19.8% |
| Operating Expenses? | $4.39M | $5.24M | $7.59M | $8.82M | $10.13M | $11.07M | $9.27M | $8.47M | $9.03M | $10.55M |
| Operating Income? | -$682,000 | -$1.26M | -$2.13M | -$2.96M | $1.92M | -$7.64M | -$854,000 | $463,000 | -$671,000 | -$6.40M |
| EBITDA? | $447,000 | -$411,000 | -$1.24M | $1.75M | -$6.01M | $643,000 | -$333,000 | $963,000 | $218,000 | -$5.09M |
| Income Before Tax | -$1.24M | -$2.10M | -$2.92M | $99,000 | $3.02M | -$727,000 | -$1.42M | -$402,000 | -$1.17M | -$6.72M |
| Income Tax Expense | $12,000 | $12,000 | $0 | $15,000 | $15,000 | $15,000 | -$77,000 | -$18,000 | $29,000 | $46,000 |
| Net Income? | -$1.25M | -$2.12M | -$3.71M | $84,000 | $3.00M | -$742,000 | -$1.34M | -$384,000 | -$1.20M | -$6.77M |
| EPS? | $-0.09 | $-0.15 | $-0.28 | $0.01 | $0.30 | $-0.08 | $-0.15 | $-0.05 | $-0.16 | $-1.05 |
| Diluted EPS? | $-0.09 | $-0.15 | $-0.28 | $0.01 | $0.30 | $-0.08 | $-0.15 | $-0.05 | $-0.16 | $-1.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality